
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79472 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Apixaban
CAS:Lactams, nesoiFormula:C25H25N5O4Color and Shape:Off-White White SolidMolecular weight:459.19065Memantine Related Compound D (1-Bromo-3,5-dimethyladamantane)
CAS:Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormula:C12H19BrColor and Shape:Yellow LiquidMolecular weight:242.06701Foscarnet Related Compound B (disodium (ethoxyoxidophosphanyl)formate)
Non-halogenated organo-phosphorous derivatives, nesoiFormula:C3H5Na2O5PColor and Shape:White PowderMolecular weight:198.02Bendamustine Related Compound F (Mannitol-1-yl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C22H33Cl2N3O7Color and Shape:White SolidMolecular weight:521.16956Paliperidone Related Compound C (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C11H15ClN2O2Color and Shape:Off-White Crystalline PowderMolecular weight:242.08221Brimonidine Related Compound B (1-(5-Bromoquinoxalin-6-yl)thiourea)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C9H7BrN4SColor and Shape:White Yellow PowderMolecular weight:281.95748Diclofenac Potassium
CAS:Aromatic amino-acids and their esters,other than those containing more than one kind of oxygen function for use as drugsFormula:C14H10Cl2KNO2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:332.97257Lorazepam Related Compound D (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C15H8Cl2N2O2Color and Shape:White PowderMolecular weight:317.99628Lufenuron Related Compound B (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide)
CAS:Ureines and their derivatives; salts thereofFormula:C14H8Cl2F2N2O3Color and Shape:Light Brown Off-White PowderMolecular weight:359.988Vardenafil Related Compound D (2-{2-Ethoxy-5-[(4-ethyl-4-oxidopiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(3H)-one)
CAS:Sulfonamides, nesoiFormula:C23H32N6O5SColor and Shape:White PowderMolecular weight:504.21549Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H18ClN3O3SColor and Shape:White Off-White SolidMolecular weight:391.075742,4-Dichlorophenol
CAS:Derivatives of phenols or phenol-alcohols, containing only halogen substitutes and their salts, nesoiFormula:C6H4Cl2OColor and Shape:White Crystalline PowderMolecular weight:161.96392Galantamine Hydrobromide Racemic
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormula:C17H21NO3·HBrColor and Shape:White Crystalline PowderMolecular weight:287.15214Moxifloxacin Related Compound F (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C22H26FN3O4Color and Shape:Off-White Yellow Tan PowderMolecular weight:415.19073Sorbitol
CAS:D-glucitol (sorbitol)Formula:C6H14O6Color and Shape:White Crystalline PowderMolecular weight:182.17 g/molTopotecan Related Compound C ((S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormula:C20H16N2O4Color and Shape:PowderMolecular weight:348.11101Dapagliflozin Related Compound A ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C21H25BrO6Color and Shape:White SolidMolecular weight:452.08345Orphenadrine Related Compound E (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormula:C18H23NOColor and Shape:Light Yellow LiquidMolecular weight:269.17796Quetiapine Related Compound B (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H17N3S·2HClColor and Shape:Off-White PowderMolecular weight:295.11432Benzphetamine Related Compound F ((1S,2S)-2-[Benzyl(methyl)amino]-1-cyclohexylpropan-1-ol hydrochloride)
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C17H27NO·HClColor and Shape:White Off-White PowderMolecular weight:297.18594

